(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.
Vivani Medical's earnings in 2026 is -$26,609,000.On average, 4 Wall Street analysts forecast VANI's earnings for 2026 to be -$28,060,747, with the lowest VANI earnings forecast at -$29,034,196, and the highest VANI earnings forecast at -$26,664,058.
In 2027, VANI is forecast to generate -$41,443,564 in earnings, with the lowest earnings forecast at -$39,818,327 and the highest earnings forecast at -$42,662,493.